Regulations for Registration of Medicinal Products Article 86

The review criteria for concentrated Chinese medicine preparations are as follows:1. In principle, compounds shall be decocted in combination. Those whose original formula involves traditional pills or powders may be decocted separately. Donkey-hide gelatin, mirabilite, maltose, and others not suitable for adding into decocting shall not be decocted in combination with others.2. Extracts of decocted medicines may be prepared with lactose or starch, as listed in the Chinese Pharmacopoeia, or with excipients that do not affect efficacy. If the original formulation basis involves traditional pills, non-boiled traditional powders, or other medicines approved by the central health competent authority, the extract may be prepared with Chinese medicine base powders.3. The levels of microorganisms, heavy metals, and pesticide residues in concentrated Chinese medicine preparations shall be within the limits announced by the central health competent authority.4. The ratio of extracts to excipients should be 1:1 in principle, with an upper limit of 1:3.5. The ratio of crude drugs actually produced to extracts shall be up to 15% more or less than the figure specified in the application.The quantitative method, specifications, and required materials for marker ingredients of concentrated Chinese medicine preparations shall be in compliance with the regulations announced by the central health competent authority.
中文原文 藥品查驗登記審查準則第86條
中藥濃縮製劑之審查基準如下:
一、複方以合併煎煮為原則。
原方為傳統丸、散者,得分別煎煮;阿膠、芒硝、飴糖及其他不能加入煎煮者,不得合併煎煮。
二、煎煮抽出之浸膏,得以中華藥典收載之乳糖、澱粉或不影響藥效之賦形劑調製;其原方依據為傳統丸、非煮散之傳統散或其他經中央衛生主管機關核准者,亦得以中藥原末調製。
三、中藥濃縮製劑微生物、重金屬、農藥殘留限量,應符合中央衛生主管機關公告之規定。
四、浸膏與賦形劑比例,以一比一為原則,以一比三為上限。
五、實際生產之生藥與浸膏比例倍數,不得超過申請值上下百分之十五。
中藥濃縮製劑之指標成分定量法、規格及所需檢附資料,應符合中央衛生主管機關公告之規定。

English translation for reference only; the Chinese text prevails. Not legal advice.